MRNA Earnings Moderna
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–27 of 27
| Q2 2026 | 2026-06-30 | -5.36 | 2026-07-31 | 10-Q |
| Q1 2026 | 2026-03-31 | -3.40 | 2026-05-01 | 10-Q |
| FY 2025 | 2025-12-31 | -7.26 | 2026-02-20 | 10-K |
| Q3 2025 | 2025-09-30 | -5.15 | 2025-11-06 | 10-Q |
| Q2 2026 | 2025-06-30 | -4.64 | 2026-07-31 | 10-Q |
| Q1 2026 | 2025-03-31 | -2.52 | 2026-05-01 | 10-Q |
| FY 2025 | 2024-12-31 | -9.28 | 2026-02-20 | 10-K |
| Q3 2025 | 2024-09-30 | -6.37 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -6.41 | 2025-08-01 | 10-Q |
| Q1 2025 | 2024-03-31 | -3.07 | 2025-05-01 | 10-Q |
| FY 2025 | 2023-12-31 | -12.33 | 2026-02-20 | 10-K |
| Q3 2024 | 2023-09-30 | -12.89 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -3.39 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.19 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | 20.12 | 2025-02-21 | 10-K |
| Q3 2023 | 2022-09-30 | 16.46 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | 13.85 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | 8.58 | 2023-05-04 | 10-Q |
| FY 2023 | 2021-12-31 | 28.29 | 2024-02-23 | 10-K |
| Q3 2022 | 2021-09-30 | 17.00 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | 9.30 | 2022-08-03 | 10-Q |
| Q1 2022 | 2021-03-31 | 2.84 | 2022-05-04 | 10-Q |
| FY 2022 | 2020-12-31 | -1.96 | 2023-02-24 | 10-K |
| Q3 2021 | 2020-09-30 | -1.26 | 2021-11-04 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.66 | 2021-08-05 | 10-Q |
| Q1 2021 | 2020-03-31 | -0.35 | 2021-05-06 | 10-Q |
| FY 2021 | 2019-12-31 | -1.55 | 2022-02-25 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.